Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas

Globally, there are over half a million new patients with head and neck squamous cell carcinomas (HNSCC) every year. The current therapeutic approaches to HNSCC are surgery and adjuvant radiotherapy. These approaches carry a high incidence of metastasis or recurrence from HNSCC cells’ radioresistanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yu-Chieh, Lee, Wei-Chang, Wang, Chih-Chun, Yeh, Shyh-An, Chen, Wen-Hui, Chen, Po-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778923/
https://www.ncbi.nlm.nih.gov/pubmed/36555391
http://dx.doi.org/10.3390/ijms232415749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778923/
https://www.ncbi.nlm.nih.gov/pubmed/36555391
http://dx.doi.org/10.3390/ijms232415749

Ejemplares similares